STOCK TITAN

Twist Bioscience Launches Enzymatic Fragmentation Library Preparation Kit for High Uniformity, High-Yield Amplification, Streamlined Next Generation Sequencing Workflow for Targeted Applications

Rhea-AI Impact
(Low)
Rhea-AI Sentiment
(Neutral)
Tags

Twist Bioscience Corporation (Nasdaq: TWST) today launched the Twist Library Preparation Enzymatic Fragmentation Kit 2.0, a robust all-in-one solution designed to maximize accuracy and efficiency in library construction and amplification when conducting next-generation sequencing (NGS). The kit is optimized for challenging NGS applications including liquid biopsy, somatic variant testing and genome-wide association studies. In addition, the kit excels in preparing samples where the amount of sample input DNA is either very limited or heavily degraded, as in the case of many banked oncology samples.

Twist Library Preparation Enzymatic Fragmentation Kit 2.0, a robust all-in-one solution designed to maximize accuracy and efficiency in library construction and amplification when conducting next-generation sequencing (NGS) for targeted applications. (Photo: Business Wire)

Twist Library Preparation Enzymatic Fragmentation Kit 2.0, a robust all-in-one solution designed to maximize accuracy and efficiency in library construction and amplification when conducting next-generation sequencing (NGS) for targeted applications. (Photo: Business Wire)

“Utilizing robust sample preparation technologies to generate sequencing libraries sets the stage for high-quality data and accurate results,” said Emily M. Leproust, Ph.D., CEO and co-founder of Twist B

Twist Bioscience

NASDAQ:TWST

TWST Rankings

TWST Latest News

TWST Stock Data

2.35B
58.69M
2.16%
112.29%
15.59%
Diagnostics & Research
Biological Products, (no Disgnostic Substances)
Link
United States
SOUTH SAN FRANCISCO